Clinical trial
Effects of Erythropoietin on Cerebral Vascular Dysfunction and Anemia in…
NCT00313716 · Claudia Sue Robertson, Other · Completed
Key facts
| NCT number | NCT00313716 |
|---|---|
| Title | Effects of Erythropoietin on Cerebral Vascular Dysfunction and Anemia in Traumatic Brain Injury |
| Official title | Effects of Erythropoietin on Cerebral Vascular Dysfunction and Anemia in Traumatic Brain Injury |
| Lead sponsor | Claudia Sue Robertson, Other |
| Collaborators | National Institute of Neurological Disorders and Stroke (NINDS) NIH |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Anemia, Traumatic Brain Injury |
| Intervention type | Drug, Other |
| Interventions | recombinant human erythropoietin, rhEpo, placebo |
| Enrollment | 200 |
| Start date | Apr 1, 2006 |
| Primary completion | Mar 1, 2013 |
| Completion | Mar 1, 2013 |
| First posted | Apr 12, 2006 |
| Last update posted | Sep 10, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: